Pathogenesis, Targeted Therapeutics, and New Vaccines for Childhood Disease
Pathogenesis, Targeted Therapeutics, and New Vaccines for Childhood Disease
批准号:
9217660
负责人:
STEVEN A. WEBBER
金额:
$34.57万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-02-08 至 2020-11-30
关键词:
AptitudeAreaCancer BiologyChild health careChildhoodCollaborationsColumbidaeCommunicable DiseasesCore FacilityCoupledDevelopmentDiabetes MellitusDiseaseEnvironmentEvaluationFacultyFundingGenerationsGoalsGrantGroup MeetingsHeart DiseasesHospitalsInternationalLaboratory ResearchLeadershipLung diseasesMedical centerMentorsMentorshipMetabolismMolecularNCI Scholars ProgramObesityPathogenesisPeer GroupPhysiciansPositioning AttributeResearchResearch PersonnelResourcesSECTM1 geneScientistTrainingTraining ProgramsUnderrepresented MinorityUnited States National Institutes of HealthVaccinescardiogenesiscareercareer developmentcollaborative environmentlaboratory facilitylung developmentmedical schoolsmeetingsmultidisciplinarynervous system disordernext generationnovel therapeuticsnovel vaccinespediatric departmentpediatricianpeerprematureprogramstargeted treatmenttherapeutic targettherapeutic vaccine
中文摘要
英文摘要
DESCRIPTION (provided by applicant): The goal of this new application is to establish at Vanderbilt a mentored training program for early career pediatricians possessing both the aptitude and passion to become a new generation of basic and translational physician scientists. The overarching theme for the program is elucidation of the molecular and cellular pathogenesis of childhood diseases, leading to identification of therapeutic targets for the development of new drugs, biologics and vaccines. We will focus on career development in the following areas of child health where Vanderbilt has internationally recognized programs of discovery combined with a record of sustained excellence in research mentorship, namely: 1) Lung Disease and Development, including lung disease of prematurity; 2) Heart Disease and Development; 3) Obesity and Metabolism (including diabetes) 4) Neurological Disorders; 5) Cancer Biology and 6) Infectious Diseases of Childhood. The program offers an integrated pediatric department and medical school training program for four pediatric K12 scholars to receive up to three years of support that includes intense scientific mentorship and personalized career development. The scholars will have access to a cadre of well-established faculty including 25 carefully selected basic and translational senior investigators with sustained NIH funding coupled with an extensive and successful track record of mentoring early career scholars. In addition, we have carefully selected 10 pediatric mentors-in- training, most with R01 funding that will be well positioned for full mentorship of K12 scholars at the completion of this cycle. The Department of Pediatrics is fully integrated into the Vanderbilt School of Medicine and Medical Center, which ranks in the top 10 in NIH funding. All academic departments, hospitals, research laboratories and core facilities reside on a single campus offering an integrated research environment for early career physician scientists. The Department currently has 6 T32 grants providing an existing pipeline of K12 scholars. The departmental leadership will also conduct a national search to identify a group of K12 scholars, including underrepresented minorities that will thrive in this highly collaborative environment. Each scholar will have an individualized training program developed by the program and training directors in collaboration with a multidisciplinary mentorship team and will be supported by a broad array of institutional and departmental resources. Each scholar will participate in regular peer-to-peer group meetings including twice-monthly career development seminars with other campus K-awardees, bi-weekly lunch meetings with the training directors alternating with bi-weekly K12 peer-to-peer `Work-in-Progress' meetings, weekly departmental research seminars, regular mentorship committees (at a minimum every 6 months), and annual formal evaluations of scholars and program. They will also have confidential face-to-face meetings with two outside advisors (former and current Pediatric Chairs, Drs. Arnold Strauss and George Dover). Taken together, these multiple efforts provide an optimal environment for developing the next generation of pediatric physician scientists.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Vanderbilt Stimulating Access to Research in Residency (V-StARR)
-
批准号:10591987
-
项目类别:
-
资助金额:$37.89万
-
财政年份:2023
-
负责人:STEVEN A. WEBBER
-
依托单位:
Chronic Graft Destruction: Interplay of Allo- and Autoantibodies and Nonadherence
-
批准号:9590743
-
项目类别:
-
资助金额:$39.64万
-
财政年份:2018
-
负责人:STEVEN A. WEBBER
-
依托单位:
Vanderbilt Stimulating Access to Research in Residency (V-StARR)
-
批准号:10201735
-
项目类别:
-
资助金额:$32.2万
-
财政年份:2018
-
负责人:STEVEN A. WEBBER
-
依托单位:
Pathogenesis, Targeted Therapeutics, and New Vaccines for Childhood Disease
-
批准号:10372216
-
项目类别:
-
资助金额:$44.0万
-
财政年份:2016
-
负责人:STEVEN A. WEBBER
-
依托单位:
Pathogenesis, Targeted Therapeutics, and New Vaccines for Childhood Disease
-
批准号:10225917
-
项目类别:
-
资助金额:$44.0万
-
财政年份:2016
-
负责人:STEVEN A. WEBBER
-
依托单位:
Chronic Graft Destruction: Interplay of Allo- and Autoantibodies and Nonadherence
-
批准号:8466120
-
项目类别:
-
资助金额:$117.42万
-
财政年份:2013
-
负责人:STEVEN A. WEBBER
-
依托单位:
Chronic Graft Destruction: Interplay of Allo- and Autoantibodies and Nonadherence
-
批准号:8606403
-
项目类别:
-
资助金额:$84.55万
-
财政年份:2013
-
负责人:STEVEN A. WEBBER
-
依托单位:
Chronic Graft Destruction: Interplay of Allo- and Autoantibodies and Nonadherence
-
批准号:8996113
-
项目类别:
-
资助金额:$14.64万
-
财政年份:2013
-
负责人:STEVEN A. WEBBER
-
依托单位:
Alloantibodies in Cardiac Transplantation - Intervention, Outcomes and Mechanisms
-
批准号:8034232
-
项目类别:
-
资助金额:$113.68万
-
财政年份:2008
-
负责人:STEVEN A. WEBBER
-
依托单位:
Alloantibodies in Cardiac Transplantation - Intervention, Outcomes and Mechanisms
-
批准号:7914250
-
项目类别:
-
资助金额:$120.26万
-
财政年份:2008
-
负责人:STEVEN A. WEBBER
-
依托单位:
Alloantibodies in Cardiac Transplantation - Intervention, Outcomes and Mechanisms
-
批准号:7451546
-
项目类别:
-
资助金额:$115.19万
-
财政年份:2008
-
负责人:STEVEN A. WEBBER
-
依托单位:
Alloantibodies in Cardiac Transplantation - Intervention, Outcomes and Mechanisms
-
批准号:8265871
-
项目类别:
-
资助金额:$54.76万
-
财政年份:2008
-
负责人:STEVEN A. WEBBER
-
依托单位:
Alloantibodies in Cardiac Transplantation - Intervention, Outcomes and Mechanisms
-
批准号:7575219
-
项目类别:
-
资助金额:$121.09万
-
财政年份:2008
-
负责人:STEVEN A. WEBBER
-
依托单位:
Alloantibodies in Cardiac Transplantation - Intervention, Outcomes and Mechanisms
-
批准号:8590939
-
项目类别:
-
资助金额:$59.32万
-
财政年份:2008
-
负责人:STEVEN A. WEBBER
-
依托单位:
Optimizing Outcome After Pediatric Heart Transplantation
-
批准号:6854545
-
项目类别:
-
资助金额:$278.24万
-
财政年份:2004
-
负责人:STEVEN A. WEBBER
-
依托单位:
Optimizing Outcome After Pediatric Heart Transplantation
-
批准号:7189873
-
项目类别:
-
资助金额:$212.31万
-
财政年份:2004
-
负责人:STEVEN A. WEBBER
-
依托单位:
Optimizing Outcome After Pediatric Heart Transplantation
-
批准号:6698906
-
项目类别:
-
资助金额:$282.63万
-
财政年份:2004
-
负责人:STEVEN A. WEBBER
-
依托单位:
Optimizing Outcome After Pediatric Heart Transplantation
-
批准号:7344815
-
项目类别:
-
资助金额:$203.26万
-
财政年份:2004
-
负责人:STEVEN A. WEBBER
-
依托单位:
Optimizing Outcome After Pediatric Heart Transplantation
-
批准号:7046076
-
项目类别:
-
资助金额:$243.77万
-
财政年份:2004
-
负责人:STEVEN A. WEBBER
-
依托单位:
Thymic Tolerance in Pediatric Heart Transplantation
-
批准号:6772507
-
项目类别:
-
资助金额:$25.93万
-
财政年份:2004
-
负责人:STEVEN A. WEBBER
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: